March 19-20: Meet us at Advanced Therapies 2024
Looking forward to seeing you Advanced Therapies 2024 at Booth 127!
Cutting edge process development insights and news from APC.
Looking forward to seeing you Advanced Therapies 2024 at Booth 127!
APC & VLE Therapeutics is looking forward to seeing you at DCAT, a premier global event based in NYC where biopharmaceutical development and manufacturing professionals gather to convene, forge connections, brainstorm, and foster collaboration for the upcoming year.
APC & VLE Therapeutics is looking forward to seeing you at Bioprocessing Summit, in Barcelona which brings together upstream, downstream, bioproduction, analytical, and formulation professionals to advance the manufacture, quality, and control of biological and genetic therapies.
In this webinar, Guangyang Hou, a Senior Process Development Engineer at APC, explores how model-supported approaches in conjunction with the implementation of Process Analytical Technologies (PAT) and continuous processing, can minimize human intervention whilst drastically reducing development times.
Looking forward to seeing you November 14-16, 2023 in San Diego, CA USA at Booth 13!
We will be at booth 77 Oct 16-19, 2023 in Barcelona to discuss your vaccine development and manufacturing challenges. Don't miss the presentation and technical poster from our technical experts.
Looking forward to seeing you November 5-10, 2023 in Orlando FL USA at Booth 314. Don't miss talks on automation, modelling, and continuous crystallization from our subject matter experts.
Visit our unique “Medicine Accelerator” facility in Dublin where we’re redefining the future of pharmaceutical manufacturing through our unwavering commitment to a groundbreaking concept – "Process Advancing Medicine."
In this webinar, we will explore the development of a 2nd generation downstream process for a complex biotherapeutic and discuss strategies to significantly reduce the number of unit operations, increase yields, reduce costs, and accelerate time-to-market while meeting CQA specifications.
[PANEL DISCUSSION] CMC data is often fragmented, siloed and lacks context - causing regulatory bottlenecks, manufacturing delays & quality issues.